On 12/12/23, Cryo-Cell International Inc (NYSEAMERICAN: CCEL) stock suffered a major decline of -11.8%, closing at $5.82. Moreover, unusually high trading volume at 150% of normal accompanied the decline. The stock has been exceptionally strong relative to the market over the last nine months and has risen 3.7% during the last week.
Current PriceTarget Research Rating
CCEL’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.
Cryo-Cell International is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment